2009 Presentations
Hormetic Immune Signaling… Initiates Neurological Preventative Health
R.P. Kraig, H.M. Mitchell, B. Christie-Pope, D.M. White, and P.E. Kunkler, The University of Chicago. [PDF]
Predicting Low Dose Effects for Chemicals in High Through-Put Studies
Edward J. Stanek III and Edward Calabrese, UMass-Amherst. [PDF]
Inhibitors of Angiogenesis Can Exhibit Bell-Shaped and U-Shaped Dose-Response Curves: Relevance for Cancer Therapy
Dr. Andrew R. Reynolds, Tumour Angiogenesis Group, Breakthrough Breast Cancer Research Center, The Institute of Cancer Research. [PDF]
Ecosystems Biology, Hormetic Responses and Non-Targeted Effects – From the Gene to the Stream!
Carmel Mothersill, Colin Seymour. [PDF]
Hormesis and Its Potential Implications for the Pharmaceutical Industry
Kenneth I. Maynard, PhD, FAHA, Sanofi-aventis, US, Inc. [PDF]
Stimulating Hormetic Signaling Pathways to Improve Brain Health
Mark Mattson, National Institute on Aging, Intramural Research Program. [PDF]
Biphasic Dose Responses in Low Level Light Therapy
Michael R Hamblin PhD, Ying-Ying Huang, Aaron Chih-Hao Chen, James Carroll. [PDF]
